[1] White NJ, Hien TT, Nosten FH. A brief history of Qinghaosu[J]. Trends Parasitol, 2015, 31(12): 607610. DOI: 10.1016/j.pt.2015.10.010.
[2] CrespoOrtiz MP, Wei MQ. Antitumor activity of artemisinin and its derivatives: from a wellknown antimalarial agent to a potential anticancer drug[J]. J Biomed Biotechnol, 2012, 2012: 247597. DOI: 10.1155/2012/247597.
[3] Tan W, Lu J, Huang M, et al. Anticancer natural products isolated from chinese medicinal herbs[J]. Chin Med, 2011, 6(1): 27. DOI: 10.1186/17498546627.
[4] Du JH, Zhang HD, Ma ZJ, et al. Artesunate induces oncosislike cell death in vitro and has antitumor activity against pancreatic cancer xenografts in vivo[J]. Cancer Chemother Pharmacol, 2010, 65(5): 895902. DOI: 10.1007/s0028000910955.
[5] Ho WE, Peh HY, Chan TK, et al. Artemisinins: pharmacological actions beyond antimalarial[J]. Pharmacol Ther, 2014, 142(1): 126139. DOI: 10.1016/j.pharmthera.2013.12.001.
[6] Yan X, Yu Y, Ji P, et al. Antitumor activity of endoperoxideiron chelator conjugatesdesign, synthesis and biological evaluation[J]. Eur J Med Chem, 2015, 102: 180187. DOI: 10.1016/j.ejmech.2015.07.040.
[7] Beekman AC, Wierenga PK, Woerdenbag HJ, et al. Artemisininderived sesquiterpene lactones as potential antitumour compounds: cytotox action against bone marrow and tumour cells[J]. Planta Med, 1998, 64(7): 615619.
[8] Mercer AE, Maggs JL, Sun XM, et al. Evidence for the involvement of carboncentered radicals in the induction of apoptotic cell death by artemisinin compounds[J]. J Biol Chem, 2007, 282(13): 93729382.
[9] Mercer AE, Copple IM, Maggs JL, et al. The role of heme and the mitochondrion in the chemical and molecular mechanisms of mammalian cell death induced by the artemisinin antimalarials[J]. J Biol Chem, 2011, 286(2): 987996.
[10] Yang Y, Zhang X, Wang X, et al. Enhanced delivery of artemisinin and its analogues to cancer cells by their adducts with human serum transferrin [J]. Int J Pharm, 2014, 467(12): 113122.
[11] Michaelis M, Kleinschmidt MC, Barth S, et al. Anticancer effects of artesunate in a panel of chemoresistant neuroblastoma cell lines[J]. Biochem Pharmacol, 2010, 79(2): 130136. DOI: 10.1016/j.bcp.2009.08.013.
[12] Zhao F, Wang H, Kunda P, et al. Artesunate exerts specific cytotoxicity in retinoblastoma cells via CD71[J]. Oncol Rep, 2013, 30(3): 14731482. DOI: 10.3892/or.2013.2574.
[13] Wang SJ, Gao Y, Chen H, et al. Dihydroartemisinin inactivates NFkappaB and potentiates the antitumor effect of gemcitabine on pancreatic cancer both in vitro and in vivo[J]. Cancer Lett, 2010, 293(1): 99108. DOI: 10.1016/j.canlet.2010.01.001.
[14] Zhang HT, Wang YL, Zhang J, et al. Artemisinin inhibits gastric cancer cell proliferation through upregulation of p53[J]. Tumour Biol, 2014, 35(2): 14031409.
[15] Mondal A, Chatterji U. Artemisinin represses telomerase subunits and induces apoptosis in HPV39 infected human cervical cancer cells[J]. J Cell Biochem, 2015, 116(9): 19681981. DOI: 10.1002/jcb.25152.
[16] Xu Q, Li ZX, Peng HQ, et al. Artesunate inhibits growth and induces apoptosis in human osteosarcoma HOS cell line in vitro and in vivo[J]. J Zhejiang Univ Sci B, 2011, 12(4): 247255.
[17] Lu M, Sun L, Zhou J, et al. Dihydroartemisinin induces apoptosis in colorectal cancer cells through the mitochondriadependent pathway[J]. Tumour Biol, 2014, 35(6): 53075314. DOI: 10.1007/s1327701416919.
[18] He Q, Shi J, Shen XL, et al. Dihydroartemisinin upregulates death receptor 5 expression and cooperates with TRAIL to induce apoptosis in human prostate cancer cells[J]. Cancer Biol Ther, 2010, 9(10): 819824.
[19] Mi YJ, Geng GJ, Zou ZZ, et al. Dihydroartemisinin inhibits glucose uptake and cooperates with glycolysis inhibitor to induce apoptosis in nonsmall cell lung carcinoma cells[J]. PLoS One, 2015, 10(3): e0120426. DOI: 10.1371/journal.pone.0120426.
[20] Zhang JL, Wang Z, Hu W, et al. DHA regulates angiogenesis and improves the efficiency of CDDP for the treatment of lung carcinoma[J]. Microvasc Res, 2013, 87: 1424. DOI: 10.1016/j.mvr.2013.02.006.
[21] Wang SJ, Sun B, Cheng ZX, et al. Dihydroartemisinin inhibits angiogenesis in pancreatic cancer by targeting the NFκB pathway[J]. Cancer Chemother Pharmacol, 2011, 68(6): 14211430. DOI: 10.1007/s0028001116437. |